BioDiscovery Resources

BioDiscovery News

Top 25 Biotech CEOs of 2020 - Soheil Shams

Since the advent of advanced genomics, and the subsequent rise of automation, the data generated in clinical testing and research sees a 100 fold increase each year making the storage, security and management of patient data quite a daunting task for companies to mine the data to find the factors that drive a patient’s disease. That’s where BioDiscovery comes in. Their flagship solution NxClinical, is a unique software tool for integrated analysis of copy number, sequence variants, and allelic changes obtained from multiple technologies. The solution combines NGS and Array data through advanced mining and filtering techniques which allows the data to be clear and digestible for clinicians. 

BioDiscovery - A Top 10 Genetic Diagnostic Company

Since the advent of advanced genomics, and the subsequent rise of automation, the data generated in clinical testing and research sees a 100 fold increase each year making the storage, security and management of patient data quite a daunting task for companies to mine the data to find the factors that drive a patient’s disease. That’s where BioDiscovery comes in. Their flagship solution NxClinical, is a unique software tool for integrated analysis of copy number, sequence variants, and allelic changes obtained from multiple technologies. The solution combines NGS and Array data through advanced mining and filtering techniques which allows the data to be clear and digestible for clinicians. 

BioDiscovery Designates Children’s Hospital of Los Angeles as a Center of Excellence for Clinical Genomics

Children’s Hospital of Los Angeles (CHLA), an award-winning hospital with comprehensive medical care services and programs for children, has signed on as a BioDiscovery Center of Excellence for Clinical Genomics to serve as a reference site for others seeking information and training on BioDiscovery’s NxClinical software.

BioDiscovery launches the NxClinical Center of Excellence initiative with Victorian Clinical Genetics Services as its first partner

BioDiscovery launches the NxClinical Center of Excellence initiative with Victorian Clinical Genetics Services as its first partner

BioDiscovery’s NxClinical software augments PerkinElmer Genomics newborn screening and genomic testing services in labs around the world

PerkinElmer Genomics has selected BioDiscovery's NxClinical software as its choice for genomic data analysis for its services.

BioDiscovery releases Nexus Copy Number 10.0, a single solution for copy number estimation from arrays, WES, WGS, shallow, and targeted sequencing

Nexus Copy Number 10.0 is a highly robust, intuitive, and multi-platform software for both copy number calling and downstream statistical analyses. A key feature of Nexus Copy Number is its ability to derive high quality copy number calls from many flavors of NGS (whole exome, whole genome, shallow, targeted panel, and normal depth of coverage sequencing).

BioDiscovery Inc. Forms Partnership with Be Creative Lab (Beijing) Co. Ltd. For Distribution of NxClinical Software

BioDiscovery announced today an agreement with Be Creative Lab in Beijing, China to be the exclusive reseller and distributor of BioDiscovery products in China.

Ambry Genetics Selects BioDiscovery’s NxClinical Software for Analysis, Management, and Reporting of Copy Number Events in its Clinical Genomics Workflow

Ambry Genetics selects BioDiscovery’s NxClinical software for analysis, management, and reporting of copy number events in its clinical genomics workflow.